Budget Amendment ID: FY2024-S3-564

EHS 564

Misoprostol-Only Pilot Program and Study

Ms. Rausch moved that the proposed new text be amended in section 2, in item 4513-1005, by inserting the following:- “; provided further, that not less than $500,000 shall be expended to Ibis Reproductive Health, Inc. to develop and implement a misoprostol-only medication abortion pilot program and study; provided further, that the pilot shall support the creation of collaborative physician-pharmacist agreements for misoprostol-only abortion; provided further, that the pharmacies included in the pilot shall be geographically diverse and include at least one hospital-based pharmacy and at least one retail pharmacy; provided further, that Ibis Reproductive Health, Inc. shall collect and analyze data from patients and pharmacists about the pilot, including without limitation patient experience, patient access to initial and follow-up care, patient preference, medication regimen efficacy, and pharmacist experience; provided further, that not later than March 30, 2024, Ibis Reproductive Health, Inc., in consultation with Reproductive Equity Now, Inc., shall issue an interim report on pilot participation, data collected, and study results, including without limitation any recommendations for pilot and study extension, to the joint committee on public health and the senate and house committees on ways and means”; and by striking out the figure “$21,460,000” and inserting in place thereof the following figure:- “$21,960,000”.